General
Preferred name
IOPAMIDOL
Synonyms
IOHEXOL ()
SQ-13396 ()
Niopam ()
Iopamiron ()
Iopamiro ()
B-15000 ()
Isovue ()
Iopamiro, Isovue, Iopamiron, Niopam, Solutrast,B-15000,SQ-13396 ()
Isovue-200 ()
Scanlux-300 ()
Iopamidol-200 ()
Isovue-250 ()
Iopamidol-300 ()
Iopamidol-250 ()
Isovue-M 300 ()
Isovue-370 ()
Isovue-300 ()
Iopamidol-370 ()
Isovue-128 ()
Scanlux-370 ()
SQ 13,396 ()
Isovue-M 200 ()
P&D ID
PD001698
CAS
66108-95-0
60166-93-0
Tags
available
drug
Approved by
FDA
First approval
1985
Drug Status
approved
Max Phase
4.0
Drug indication
Renal cell carcinoma
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
29
DESCRIPTION
Iopamidol (SQ-13396) is a benzenedicarboxamide compound. It has a role as a radioopaque medium, an environmental contaminant and a xenobiotic.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
14
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
NCATS Inxight Approved Drugs
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
35
Molecular Weight
776.85
Hydrogen Bond Acceptors
8
Hydrogen Bond Donors
8
Rotatable Bonds
10
Ring Count
1
Aromatic Ring Count
1
cLogP
-1.01
TPSA
188.45
Fraction CSP3
0.47
Chiral centers
1.0
Largest ring
6.0
QED
0.14
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Indication
contrast agent
MOA
radiopaque medium
Source data
